INSERM, U694, Angers, 49000, France.
Neurogenetics. 2010 Feb;11(1):127-33. doi: 10.1007/s10048-009-0207-z. Epub 2009 Jul 18.
Charcot-Marie-Tooth type 2A disease (CMT2A), a dominantly inherited peripheral neuropathy, is caused by mutations in MFN2, a mitochondrial fusion protein. Having previously demonstrated a mitochondrial coupling defect in CMT2A patients' fibroblasts, we here investigate mitochondrial oxygen consumption and the expression of adenine nucleotide translocase (ANT) and uncoupling proteins from eight other patients with the disease. The mitochondrial uncoupling was associated with a higher respiratory rate, essentially involving complex II proteins. Furthermore, a twofold increase in the expression of ANT led to the reduced efficiency of oxidative phosphorylation in CMT2A cells, suggesting that MFN2 plays a role in controlling ATP/ADP exchanges.
Charcot-Marie-Tooth 型 2A 病(CMT2A)是一种显性遗传性周围神经病,由线粒体融合蛋白 MFN2 的突变引起。我们之前在 CMT2A 患者的成纤维细胞中发现了线粒体偶联缺陷,在此研究了来自其他八位患者的线粒体耗氧量以及腺嘌呤核苷酸转位酶(ANT)和解偶联蛋白的表达。线粒体解偶联与更高的呼吸率有关,主要涉及复合物 II 蛋白。此外,ANT 表达增加两倍导致 CMT2A 细胞氧化磷酸化效率降低,表明 MFN2 在控制 ATP/ADP 交换中发挥作用。